When did 2SEVENTY BIO INC (TSVT) report earnings last quarter?
2SEVENTY BIO INC (TSVT) last reported earnings on 5/8/2025.
NASDAQ:TSVT • US9013841070
Past quarterly earnings results for 2SEVENTY BIO INC (TSVT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | -0.17 | - | 82.83% | 22.917M | 14.242M | 60.91% | 84.29% | |
| Q4 2024 | -0.37 | -0.27 | -36.88% | 66.67% | 2.926M | 12.538M | -76.66% | -72.61% |
| Q3 2024 | -0.19 | -0.25 | 22.77% | 81.00% | 13.534M | 15.337M | -11.76% | 12.46% |
| Q2 2024 | 0.45 | -0.66 | 168.10% | 154.22% | 8.967M | 14.479M | -38.07% | -75.12% |
| Q1 2024 | -1.01 | -0.83 | -21.92% | 6.48% | 12.435M | 14.367M | -13.45% | -70.12% |
| Q4 2023 | -1.11 | -1.01 | -9.91% | -85.00% | 10.684M | 15M | -28.77% | -80.98% |
| Q3 2023 | -1.00 | -1.05 | 4.66% | 43.18% | 12.034M | 31.8M | -62.16% | -10.26% |
| Q2 2023 | -0.83 | -1.09 | 23.59% | 58.91% | 36.048M | 37.616M | -4.17% | 167.42% |
| Q1 2023 | -1.08 | -1.22 | 11.27% | 66.29% | 41.621M | 22.751M | 82.94% | 393.72% |
| Q4 2022 | -0.60 | -1.64 | 63.37% | 76.47% | 56.18M | 15.83M | 254.90% | 250.47% |
| Q3 2022 | -1.76 | -1.84 | 4.40% | 32.82% | 13.41M | 12.613M | 6.32% | -30.37% |
| Q2 2022 | -2.02 | -2.32 | 12.99% | - | 13.48M | 16.849M | -20.00% | -29.90% |
| Q1 2022 | -3.20 | -2.10 | -52.93% | - | 8.43M | 23.114M | -63.53% | - |
| Q4 2021 | -2.55 | -2.89 | 11.85% | - | 16.03M | 13.179M | 21.63% | -93.54% |
| Q3 2021 | -2.62 | -2.76 | 5.22% | - | 19.26M | 8.71M | 121.13% | - |
| Q2 2021 | - | - | 19.229M | - | -91.25% | |||
| Q4 2020 | - | - | 248.122M | - | - | |||
| Q2 2020 | - | - | 219.782M | - | - |
Notes
2SEVENTY BIO INC (TSVT) last reported earnings on 5/8/2025.
2SEVENTY BIO INC (TSVT) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, 2SEVENTY BIO INC (TSVT) has beaten EPS estimates in 2 out of 4 releases.